Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fusidic acid resistance in Staphylococcus aureus.

Literature DB >> 14709515

Fusidic acid resistance in Staphylococcus aureus.

Abstract

This review summarises current knowledge of the microbiological and clinical aspects of fusidic acid resistance in Staphylococcus aureus, and makes recommendations about fusidic acid prescribing and further research.

Entities: Chemical Species

Mesh：

Substances：

Year: 2004 PMID： 14709515 PMCID： PMC1755935 DOI： 10.1136/adc.2003.019695

Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791

43 in total

1. The antibiotic sensitivity of bacteria isolated from the blood of patients in St Thomas' Hospital, 1969-1988.

Authors: I Phillips; A King; W R Gransden; S J Eykyn
Journal: J Antimicrob Chemother Date: 1990-04 Impact factor: 5.790

Review 2. Topical antibiotic therapy: current status and future prospects.

Authors: E A Eady; J H Cove
Journal: Drugs Exp Clin Res Date: 1990

3. Fusidic-acid use and resistance.

Authors: David Livermore; Dorothy James; Georgia Duckworth; Peter Stephens
Journal: Lancet Date: 2002-09-07 Impact factor: 79.321

4. Staphylococcal bacteraemia and endocarditis and fusidic acid.

Authors: S J Eykyn
Journal: J Antimicrob Chemother Date: 1990-02 Impact factor: 5.790

5. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.

Authors: S McLinn
Journal: J Am Acad Dermatol Date: 1990-05 Impact factor: 11.527

Review 6. Fusidic acid in staphylococcal bone and joint infection.

Authors: R R Coombs
Journal: J Antimicrob Chemother Date: 1990-02 Impact factor: 5.790

Review 7. The antimicrobial activity of fusidic acid.

Authors: L Verbist
Journal: J Antimicrob Chemother Date: 1990-02 Impact factor: 5.790

8. Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101.

Authors: Frances G O'Brien; Christopher Price; Warren B Grubb; John E Gustafson
Journal: J Antimicrob Chemother Date: 2002-09 Impact factor: 5.790

9. Cost-effectiveness of erythromycin versus mupirocin for the treatment of impetigo in children.

Authors: T D Rice; A K Duggan; C DeAngelis
Journal: Pediatrics Date: 1992-02 Impact factor: 7.124

10. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing.

Authors: Brendan W Mason; Anthony J Howard; John T Magee
Journal: J Antimicrob Chemother Date: 2003-03-13 Impact factor: 5.790

24 in total

1. Treatment for impetigo.

Authors: Sander Koning; Johannes C van der Wouden
Journal: BMJ Date: 2004-09-25

2. A novel staphylococcal cassette chromosomal element, SCCfusC, carrying fusC and speG in fusidic acid-resistant methicillin-resistant Staphylococcus aureus.

Authors: Yu-Tzu Lin; Jui-Chang Tsai; Hsiao-Jan Chen; Wei-Chun Hung; Po-Ren Hsueh; Lee-Jene Teng
Journal: Antimicrob Agents Chemother Date: 2013-11-25 Impact factor: 5.191

3. Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologies.

Authors: Glenn A Pankuch; Gengrong Lin; Dianne B Hoellman; Caryn E Good; Michael R Jacobs; Peter C Appelbaum
Journal: Antimicrob Agents Chemother Date: 2006-05 Impact factor: 5.191

4. Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic.

Authors: Stephen Rittenhouse; Christine Singley; Jennifer Hoover; Roni Page; David Payne
Journal: Antimicrob Agents Chemother Date: 2006-11 Impact factor: 5.191

5. Bacterial cultures, rapid strep test, and antibiotic treatment in infected hard-to-heal ulcers in primary care.

Authors: Rut F Oien; Nina Akesson
Journal: Scand J Prim Health Care Date: 2012-10-10 Impact factor: 2.581

Review 6. Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.

Authors: Prabhavathi Fernandes
Journal: Cold Spring Harb Perspect Med Date: 2016-01-04 Impact factor: 6.915

7. Identification of fusB-mediated fusidic acid resistance islands in Staphylococcus epidermidis isolates.

Authors: Hsiao-Jan Chen; Jui-Chang Tsai; Wei-Chun Hung; Sung-Pin Tseng; Po-Ren Hsueh; Lee-Jene Teng
Journal: Antimicrob Agents Chemother Date: 2011-10-03 Impact factor: 5.191

8. Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus.

Authors: Ronald N Jones; Mariana Castanheira; Paul R Rhomberg; Leah N Woosley; Michael A Pfaller
Journal: J Clin Microbiol Date: 2010-01-06 Impact factor: 5.948

Review 9. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.

Authors: Lily P H Yang; Susan J Keam
Journal: Drugs Date: 2008 Impact factor: 9.546

10. Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014.

Authors: David J Farrell; Rodrigo E Mendes; Mariana Castanheira; Ronald N Jones
Journal: Antimicrob Agents Chemother Date: 2016-05-23 Impact factor: 5.191